AI

AtaiBeckley Inc.

IPO

Public · United States · Founded 2025 · $285.0M raised

Employees
51–200
Founded
2025
Business Model
B2B
Total Funding
$285.0M
Last Round
$160.0M Series DMar 2021
Rounds
2
Type
Public

About

Clinical-stage biopharmaceutical company developing effective, rapid-acting mental health treatments formed from merger of atai Life Sciences and Beckley Psytech.

Summary

AtaiBeckley Inc. is a Biotech company based in United States, founded in 2025. It has raised $285.0M in total across 2 rounds, most recently a $160.0M Series D round in Mar 2021. Investors include Multiple investors.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

IPOJun 2021
$225.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies